AFYA News and Press, Afya Limited

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“ Afya ” or the “ Company ”), the leading medical education group and provider of medical practice solutions in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Minist...

2026-01-16 02:05:05 ET Andre Salles from UBS issued a price target of $16.00 for AFYA on 2026-01-16 05:54:00. The adjusted price target was set to $16.00. At the time of the announcement, AFYA was trading at $14.39. The overall price target consensus is at $17.75 with hi...

2026-01-16 01:15:05 ET Bernstein analyst issues MARKET PERFORM recommendation for AFYA on January 16, 2026 05:54AM ET. AFYA was trading at $14.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 5 - Buy, 2...

2026-01-16 01:15:05 ET UBS analyst issues NEUTRAL recommendation for AFYA on January 16, 2026 05:54AM ET. The previous analyst recommendation was Buy. AFYA was trading at $14.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”) , the leading medical education group and medical practice solutions provider in Brazil, announced today that Mrs. Maria Tereza Azevedo notified the Company of her intent to resign as a member of the B...

2025-12-01 08:45:00 ET Afya ( AFYA ) reported 3Q25 results this month, and also held its annual Investor Day in late October, covering strategy and detailed business metrics. ... Read the full article on Seeking Alpha For further details see: Afya's 3Q25 And ...

2025-11-13 00:46:46 ET More on Afya Afya Limited 2025 Q3 - Results - Earnings Call Presentation Afya Limited (AFYA) Q3 2025 Earnings Call Transcript Afya Limited (AFYA) Analyst/Investor Day Transcript Seeking Alpha’s Quant Rating on Afya Histor...

2025-11-12 23:01:31 ET Afya Limited (AFYA) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Renata Couto - Investor Relations Executive Manager Virgilio Deloy Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer ....

Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Br...

RWE AG ADR (RWEOY) is expected to report $0.16 for Q3 2025 Hillenbrand Inc (HI) is expected to report $0.62 for Q4 2025 Ardent Health Inc. (ARDT) is expected to report $0.42 for Q3 2025 Quince Therapeutics Inc. (QNCX) is expected to report $-0.2 for Q3 2025 GlobalFoundries Inc. (G...